Skip to main content
. 2023 Oct 31;29(14):1795–1807. doi: 10.1177/13524585231205708

Figure 3.

Figure 3.

Mean (standard error (SE)) absolute lymphocyte counts (ALCs) declined from baseline to Week 48 and plateaued to Week 96.

DMF: dimethyl fumarate; DRF: diroximel fumarate; LLN: lower limit of normal.

LLN was defined as < 0.91×109/L. The prior DMF group includes patients who rolled over from receiving DMF in EVOLVE-MS-2. The prior DRF group includes patients who rolled over from receiving DRF in EVOLVE-MS-2. De novo group includes patients who had not previously received DRF and were newly enrolled in the DRF clinical trial program.